Clinical trial · Interventional
High-flow Nasal Cannula Oxygenation Decrease Hypoxia in Gastroscopy Sedated by Propofol
High-flow Nasal Cannula Oxygenation Decrease Hypoxia in Gastroscopy Sedated by Propofol: a Randomized Multicentre Clinical Trial
NCT03332433CI-TRIAL-00034706HONCHOcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Hypoxia is the most common adverse events during sedated gastroscopy. In present study, high-flow nasal cannula oxygenation will be utilized in order to reduce the hypoxia. At the same time the feasibility and safety will be evaluated.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Adverse Event | — | UNRESOLVED | — |
| Esophagus Cancer | — | UNRESOLVED | — |
| Gastric Cancer | Malignant Gastric Neoplasm | CURATED_BROADER | 0.80 |
| Hypoxia | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| High-flow nasal cannula oxygenation | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- NO_INTERVENTION
- label
- Control group
- description
- Oxygen(2L/min) supplied with nasal catheter
- type
- EXPERIMENTAL
- label
- High-flow nasal cannula group
- description
- Oxygen(up to 60L/min) supplied with high-flow nasal cannula
- interventionNames
- Device: High-flow nasal cannula oxygenation
Primary outcomes (1)
- measure
- Incidence of hypoxia
- timeFrame
- Patients will be followed for the duration of hospital stay, an expected average of 2 hours
- description
- (75% ≤ SpO2 \< 90% for \<60 s)
Secondary outcomes (3)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * patients undergoing gastroscope * age over 18 years old * Signed informed consent form Exclusion Criteria: * Coagulation disorders or a tendency of nose bleeding; * An episode/exacerbation of congestive heart failure (CHF) that requires a change in medication, diet or hospitalization from any cause in the last 6 months; * Severe aortic stenosis or mitral stenosis; * Cardiac surgery involving thoracotomy (e.g., coronary artery bypass graft (CABG), valve replacement surgery) in the last 6 months; * Acute myocardial infarction in the last 6 months; * Acute arrhythmia (including any tachycardia - or bradycardia) with hemodynamic instability; * Diagnosed chronic obstructive pulmonary disease or current other acute or chronic lung disease requiring supplemental chronic or intermittent oxygen therapy); * Increased intracranial pressure; * ASA \>III; * Mouth, nose, or throat infection; * Fever, defined as core body temperature \> 37.5oC ; * Pregnancy, breastfeeding or positive pregnancy test * Emergency procedure
References
Publications (1)
- DERIVEDLin Y, Zhang X, Li L, Wei M, Zhao B, Wang X, Pan Z, Tian J, Yu W, Su D. High-flow nasal cannula oxygen therapy and hypoxia during gastroscopy with propofol sedation: a randomized multicenter clinical trial. Gastrointest Endosc. 2019 Oct;90(4):591-601. doi: 10.1016/j.gie.2019.06.033. Epub 2019 Jul 3. PMID 31278907